Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

China · Delayed Price · Currency is CNY

48.97

+3.46 (7.60%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Culture Medium Products	244.22M	-			53.37M	26.02M	19.71M
Culture Medium Products Growth	-	-			105.11%	32.04%	-
CDMO	52.56M	-			71.60M	32.50M	14.14M
CDMO Growth	-	-			120.31%	129.88%	-
Total	296.78M	-			124.97M	58.52M	33.84M
Total Growth	-	-			113.55%	72.92%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	202.32M	-			121.14M	46.41M	33.84M
China Growth	-	-			161.05%	37.12%	-
Overseas	94.46M	-			-	-	-
Unallocated	-	-			3.83M	12.12M	-
Unallocated Growth	-	-			-68.39%	-	-
Total	296.78M	-			124.97M	58.52M	33.84M
Total Growth	-	-			113.55%	72.92%	-

Source: S&P Global Market Intelligence.